logo

For the Inventor, By the Inventor

Bridgewater, NJ, United States of America

Dr. Reddy's Laboratories, Incorporated

Calculating rank
USPTO Granted Patents = 187

% Expired Patents = 75.4



Trademarks = 35

Forward Citations = 364

Loading Chart...
Loading Chart...

479 inventors (with patents filed for the assignee):

goldMedal Javed Iqbal (20 out of 16 patents)

silverMedal Manne Satyanarayana Reddy (18 out of 24 patents)

bronzeMedal Ranjan Chakrabarti (17 out of 35 patents)

4.  Rajeev Singh Raghuvanshi (14 out of 22 patents)

5.  Pradip Kumar Sasmal (14 out of 13 patents)

6.  Rajagopalan Ramanujam (14 out of 37 patents)

7.  Shanavas Alikunju (13 out of 10 patents)

8.  Bijay Kumar Padhi (12 out of 15 patents)

9.  Ashok Tehim (12 out of 71 patents)

10.  Vishweshwar Peddy (11 out of 12 patents)

11.  Sateesh Kandavilli (11 out of 17 patents)

12.  Venkateswarlu Akella (11 out of 15 patents)

13.  Braj Bhushan Lohray (11 out of 37 patents)

14.  Vidya Bhushan Lohray (11 out of 36 patents)

15.  Ish Khanna (9 out of 17 patents)


Core Competencies:
Therapeutic Antibody
Stable Formulations
Fusion Protein
Pharmaceutical Compositions
Topical Retinoid
Oral Composition
Solid State Forms
Cyclophosphamide
Ectoparasite Control
Kappa Opioid Receptor Agonists
Trk Inhibitors
Polymorphic Forms

187 patents:

1. 12433947 - Stable formulations of therapeutic antibody (2025-10-07),
2. 12428464 - Stable fusion protein formulation (2025-09-30),
3. 12030948 - Antibody formulation (2024-07-09),
4. 12024561 - Stable antibody formulation (2024-07-02),
5. 11639391 - Stable liquid pharmaceutical composition (2023-05-02),
6. 11390583 - Process for preparation of Siponimod, its salts and solid state forms thereof (2022-07-19),
7. 11382923 - Stable liquid formulations of cyclophosphamide and processes to prepare the same (2022-07-12),
8. 11364212 - Methods for treating inflammatory skin conditions (2022-06-21),
9. 11292793 - Solid dispersions of amorphous Lumateperone p-Tosylate (2022-04-05),
10. 11191740 - Methods for treating inflammatory skin conditions (2021-12-07),
11. 11168107 - Amine salt of obeticholic acid (2021-11-09),
12. 11168057 - Polymorphs and co-crystals of roxadustat (2021-11-09),
13. 11103517 - Pharmaceutical compositions for minocycline (2021-08-31),
14. 11084791 - Solid state forms of Lenvatinib Mesylate (2021-08-10),
15. 11059799 - Process for preparation of eribulin and intermediates thereof (2021-07-13),
Company Overview
Dr. Reddy's Laboratories, Incorporated is a prominent player in the pharmaceutical industry, headquartered in Bridgewater, NJ. The company specializes in the development and manufacturing of a diverse range of pharmaceutical formulations, focusing on innovative therapeutic solutions. Key technology areas include therapeutic antibodies, stable formulations, and fusion proteins, alongside expertise in pharmaceutical compositions and solid-state forms. Dr. Reddy's commitment to advancing healthcare is evident in its research on topical retinoids and oral compositions, catering to global markets.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Dr. Reddy's Laboratories, Incorporated USPTO Patent Assignee Logo
187 Patents

#4 in Bridgewater, NJ

#97 in New Jersey

#2,194 in US

#4,503 in the World

Bridgewater, NJ (US)
Bridgewater, NJ, United States of America

Dr. Reddy's Laboratories, Incorporated

Forward Citations = 364

479 inventors:

goldMedal Javed Iqbal (20 out of 16 patents)

silverMedal Manne Satyanarayana Reddy (18 out of 24 patents)

bronzeMedal Ranjan Chakrabarti (17 out of 35 patents)

4.  Rajeev Singh Raghuvanshi (14 out of 22 patents)

5.  Pradip Kumar Sasmal (14 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dr. Reddy's Laboratories, Incorporated. Retrieved from https://idiyas.com/company/dr-reddy-s-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…